Evidence map›Paper›PMID 27188299›Full record

ReviewCurrent HIV/AIDS reports2016

Cognitive Impairment and Persistent CNS Injury in Treated HIV.

Phillip Chan, Joanna Hellmuth, Serena Spudich, Victor Valcour

Abstract readReview
In one paragraph

Review in Current HIV/AIDS reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Preliminary In Vivo Evidence of Reduced Synaptic Density in Human Immunodeficiency Virus (HIV) Despite Antiretroviral Therapy.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Phillip ChanSEARCH-Thailand, Thai Red Cross AIDS Research Center, Bangkok, Thailand.
Joanna HellmuthMemory and Aging Center, MC: 1207, Sandler Neurosciences Building, 675 Nelson Rising Lane, Room 192C, Department of Neurology, University of California San Francisco, San Francisco, CA, 94143-1207, USA.
Serena SpudichDepartment of Neurology, Yale University, New Haven, CT, USA.
Victor ValcourMemory and Aging Center, MC: 1207, Sandler Neurosciences Building, 675 Nelson Rising Lane, Room 192C, Department of Neurology, University of California San Francisco, San Francisco, CA, 94143-1207, USA. vvalcour@memory.ucsf.edu.

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Multidisciplinary Research Fellowship in Alzheimer’s disease and Related DementiasT32AG023481 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BRUCE L MILLER, HOWARD J ROSEN · 2005 to 2026
$7.4M
Long-Term CNS Consequences of Treatment During Acute InfectionR01MH095613 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SPUDICH, SERENA S, VALCOUR, VICTOR · 2011 to 2015
$3.1M
Midcareer Mentoring Award for Patient-Oriented Research in HIV and CognitionK24MH098759 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI VALCOUR, VICTOR · 2013 to 2017
$887k
NCATS NIH HHS UL1 TR001863NIA NIH HHS T32 AG023481NIMH NIH HHS K24 MH098759NIMH NIH HHS R01 MH095613
6 · The paper itself

Abstract

The implementation of combination antiretroviral therapy (cART) has changed HIV infection into a chronic illness, conveying extensive benefits, including greater longevity and advantages for the central nervous system (CNS). However, studies increasingly confirm that the CNS gains are incomplete, with reports of persistent immune activation affecting the CNS despite suppression of plasma HIV RNA. The rate of cognitive impairment is unchanged, although severity is generally milder than in the pre-cART era. In this review, we discuss cognitive outcomes from recently published clinical HIV studies, review observations on HIV biomarkers for cognitive change, and emphasize longitudinal imaging findings. Additionally, we summarize recent studies on CNS viral invasion, CD8 encephalitis, and how CNS involvement during the earliest stages of infection may set the stage for later cognitive manifestations.

Indexed as

Antiretroviral Therapy, Highly ActiveAIDS Dementia ComplexAnti-Retroviral AgentsCD8-Positive T-LymphocytesCentral Nervous SystemCognitive DysfunctionEncephalitisHIV-1HIV InfectionsHumansMaleTreatment OutcomeViral LoadAnti-Retroviral AgentsCaRTCentral nervous systemClinical HIV studiesCNS injuryCognitive impairmentCombination antiretroviral therapyComplications of HIV and ARTHIV infectionReview

Identifiers

PMID27188299
PMCPMC4977199

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.